Delivery Order SPE2DR25D2014-SPE2DR26FA4B0
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $9.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,707.24 to AmerisourceBergen Drug Corp for 40 mg Digifab vials, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,573.38 Firm Fixed Price Delivery Order is for the supply of DIGIFAB 40 MG VIALS, a medical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,738,224 units of the pharmaceutical product DIGIFAB 40 MG VIALS. The contract has a potential value of $37,013.12 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,064.55 to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of DIGIFAB 40 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,743.59, is a Delivery Order for "DIGIFAB 40 MG VIALS" and has a firm fixed price. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,837.73, is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on February 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,842.65, is for the supply of DIGIFAB 40 MG VIALS, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
- AmerisourceBergen Drug Corp was awarded a $25,432.30 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, for CROFAB vials, with a completion date of September 30, 2025. This non-competitive delivery order is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $47,608.56 to AmerisourceBergen Drug Corp on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order was issued under a larger indefinite delivery contract (IDC) vehicle with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a $22,710.45 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 21, 2026, under a firm fixed-price contract with a completion date of January 21, 2026. This non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...